JP2013524892A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013524892A5 JP2013524892A5 JP2013505189A JP2013505189A JP2013524892A5 JP 2013524892 A5 JP2013524892 A5 JP 2013524892A5 JP 2013505189 A JP2013505189 A JP 2013505189A JP 2013505189 A JP2013505189 A JP 2013505189A JP 2013524892 A5 JP2013524892 A5 JP 2013524892A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- time
- treatment session
- hemodialysis
- dialysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001631 haemodialysis Methods 0.000 claims description 86
- 230000000322 hemodialysis Effects 0.000 claims description 86
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 73
- 229910052698 phosphorus Inorganic materials 0.000 claims description 73
- 239000011574 phosphorus Substances 0.000 claims description 73
- 238000000034 method Methods 0.000 claims description 59
- 238000000502 dialysis Methods 0.000 claims description 49
- 229910019142 PO4 Inorganic materials 0.000 claims description 25
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 25
- 239000010452 phosphate Substances 0.000 claims description 25
- 210000002966 serum Anatomy 0.000 claims description 24
- 238000000108 ultra-filtration Methods 0.000 claims description 12
- 230000017531 blood circulation Effects 0.000 claims description 9
- 238000005070 sampling Methods 0.000 claims description 8
- 230000007704 transition Effects 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 238000005259 measurement Methods 0.000 claims description 6
- 230000037396 body weight Effects 0.000 claims description 4
- 238000005534 hematocrit Methods 0.000 claims description 4
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32511310P | 2010-04-16 | 2010-04-16 | |
| US61/325,113 | 2010-04-16 | ||
| PCT/US2011/032735 WO2011130668A1 (en) | 2010-04-16 | 2011-04-15 | Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015096421A Division JP6078582B2 (ja) | 2010-04-16 | 2015-05-11 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013524892A JP2013524892A (ja) | 2013-06-20 |
| JP2013524892A5 true JP2013524892A5 (https=) | 2014-01-16 |
| JP5747072B2 JP5747072B2 (ja) | 2015-07-08 |
Family
ID=44041518
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013505189A Expired - Fee Related JP5747072B2 (ja) | 2010-04-16 | 2011-04-15 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
| JP2013505190A Expired - Fee Related JP6018567B2 (ja) | 2010-04-16 | 2011-04-15 | 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化 |
| JP2015096421A Active JP6078582B2 (ja) | 2010-04-16 | 2015-05-11 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
| JP2015178146A Expired - Fee Related JP6043850B2 (ja) | 2010-04-16 | 2015-09-10 | 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化 |
| JP2017005263A Expired - Fee Related JP6543279B2 (ja) | 2010-04-16 | 2017-01-16 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
| JP2019111351A Active JP7057321B2 (ja) | 2010-04-16 | 2019-06-14 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
| JP2022063908A Active JP7438257B2 (ja) | 2010-04-16 | 2022-04-07 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
| JP2024019498A Pending JP2024045513A (ja) | 2010-04-16 | 2024-02-13 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
Family Applications After (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013505190A Expired - Fee Related JP6018567B2 (ja) | 2010-04-16 | 2011-04-15 | 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化 |
| JP2015096421A Active JP6078582B2 (ja) | 2010-04-16 | 2015-05-11 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
| JP2015178146A Expired - Fee Related JP6043850B2 (ja) | 2010-04-16 | 2015-09-10 | 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化 |
| JP2017005263A Expired - Fee Related JP6543279B2 (ja) | 2010-04-16 | 2017-01-16 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
| JP2019111351A Active JP7057321B2 (ja) | 2010-04-16 | 2019-06-14 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
| JP2022063908A Active JP7438257B2 (ja) | 2010-04-16 | 2022-04-07 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
| JP2024019498A Pending JP2024045513A (ja) | 2010-04-16 | 2024-02-13 | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 |
Country Status (10)
| Country | Link |
|---|---|
| EP (3) | EP2558967B1 (https=) |
| JP (8) | JP5747072B2 (https=) |
| AU (2) | AU2011239489B2 (https=) |
| BR (1) | BR112012026361A2 (https=) |
| CA (2) | CA2796496C (https=) |
| CO (3) | CO6660434A2 (https=) |
| ES (2) | ES2501715T3 (https=) |
| MX (5) | MX2012012061A (https=) |
| NZ (2) | NZ602996A (https=) |
| WO (2) | WO2011130669A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9132219B2 (en) | 2010-04-16 | 2015-09-15 | Baxter International Inc. | Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis |
| US8845570B2 (en) | 2010-04-16 | 2014-09-30 | Baxter International Inc. | Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis |
| MX361881B (es) * | 2013-08-16 | 2018-12-18 | Baxter Int | Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria. |
| DE102014005122A1 (de) * | 2014-04-08 | 2015-10-08 | Fresenius Medical Care Deutschland Gmbh | Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung |
| EP3539586B1 (en) | 2014-10-10 | 2022-08-24 | NxStage Medical Inc. | Flow balancing methods |
| WO2018017623A1 (en) | 2016-07-18 | 2018-01-25 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
| US11865243B2 (en) | 2016-08-30 | 2024-01-09 | Nxstage Medical, Inc. | Parameter monitoring in medical treatment systems |
| JP2019212249A (ja) * | 2018-06-10 | 2019-12-12 | 大 益満 | プログラム及び情報処理システム |
| CA3132978A1 (en) | 2019-03-11 | 2020-09-17 | Fresenius Medical Care Holdings, Inc. | Techniques for determining acid-base homeostasis |
| WO2020237228A1 (en) | 2019-05-23 | 2020-11-26 | Nxstage Medical, Inc. | Flow synchronization devices, methods and systems |
| CN115050238B (zh) * | 2022-07-08 | 2024-03-12 | 卡斯柯信号有限公司 | 一种基于真实ctc系统的多模式切换仿真实训系统 |
| JP2024113409A (ja) | 2023-02-09 | 2024-08-22 | フィジオロガス・テクノロジーズ株式会社 | 診療支援システム |
| WO2024242176A1 (ja) | 2023-05-25 | 2024-11-28 | フィジオロガス・テクノロジーズ株式会社 | 血液透析治療支援システム |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5602116A (en) * | 1988-08-02 | 1997-02-11 | Bone Care International, Inc. | Method for treating and preventing secondary hyperparathyroidism |
| US5230702A (en) * | 1991-01-16 | 1993-07-27 | Paradigm Biotechnologies Partnership | Hemodialysis method |
| WO1994009351A1 (en) * | 1992-10-13 | 1994-04-28 | Baxter International Inc. | Fluid sampling module |
| JP2812460B2 (ja) * | 1995-10-04 | 1998-10-22 | 日機装株式会社 | 血液浄化モニタ装置 |
| JP3402360B2 (ja) * | 1998-08-21 | 2003-05-06 | 株式会社ジェイ・エム・エス | 腹膜透析システム |
| AUPP790898A0 (en) * | 1998-12-23 | 1999-01-28 | Life Therapeutics Limited | Renal dialysis |
| EP1396274B2 (en) * | 2002-09-05 | 2013-05-22 | Gambro Lundia AB | Controller for a blood treatment equipment |
| US20040048837A1 (en) * | 2002-09-06 | 2004-03-11 | Lazarus J. Michael | Method for treatment of renal disease |
| JP4379027B2 (ja) * | 2003-05-14 | 2009-12-09 | 株式会社ジェイ・エム・エス | 腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置 |
| ATE464611T1 (de) * | 2005-06-09 | 2010-04-15 | Gambro Lundia Ab | Medizinische vorrichtung und verfahren zum einrichten einer medizinischen vorrichtung |
| DE102006045437A1 (de) * | 2006-09-26 | 2008-04-03 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung und Verfahren zur Vorgabe einer Dialysierflüssigkeitsrate oder Blutflussrate für eine extrakorporale Blutbehandlung |
| US8366655B2 (en) | 2007-02-27 | 2013-02-05 | Deka Products Limited Partnership | Peritoneal dialysis sensor apparatus systems, devices and methods |
| US9028691B2 (en) | 2007-02-27 | 2015-05-12 | Deka Products Limited Partnership | Blood circuit assembly for a hemodialysis system |
| US8393690B2 (en) | 2007-02-27 | 2013-03-12 | Deka Products Limited Partnership | Enclosure for a portable hemodialysis system |
| US8409441B2 (en) * | 2007-02-27 | 2013-04-02 | Deka Products Limited Partnership | Blood treatment systems and methods |
| US8042563B2 (en) | 2007-02-27 | 2011-10-25 | Deka Products Limited Partnership | Cassette system integrated apparatus |
| US20090107335A1 (en) | 2007-02-27 | 2009-04-30 | Deka Products Limited Partnership | Air trap for a medical infusion device |
| US8562834B2 (en) | 2007-02-27 | 2013-10-22 | Deka Products Limited Partnership | Modular assembly for a portable hemodialysis system |
| EP2174292A1 (en) * | 2007-08-03 | 2010-04-14 | Koninklijke Philips Electronics N.V. | A method, apparatus, computer-readable medium and use for pharmacokinetic modeling |
| US8062513B2 (en) * | 2008-07-09 | 2011-11-22 | Baxter International Inc. | Dialysis system and machine having therapy prescription recall |
| US8168063B2 (en) * | 2008-07-09 | 2012-05-01 | Baxter International Inc. | Dialysis system having filtering method for determining therapy prescriptions |
| US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
| US9514283B2 (en) | 2008-07-09 | 2016-12-06 | Baxter International Inc. | Dialysis system having inventory management including online dextrose mixing |
| US7981281B2 (en) | 2008-07-09 | 2011-07-19 | Baxter International, Inc. | Dialysis system having regimen generation methodology |
| EP2163272B1 (en) * | 2008-09-15 | 2014-06-25 | B. Braun Avitum AG | Device to early predict the Kt/V parameter in kidney substitution treatments |
| EP2334292B1 (en) * | 2008-10-17 | 2019-05-08 | Fresenius Medical Care Holdings, Inc. | Method of determining a phosphorus binder dosage for a dialysis patient |
-
2011
- 2011-04-15 MX MX2012012061A patent/MX2012012061A/es active IP Right Grant
- 2011-04-15 NZ NZ602996A patent/NZ602996A/en not_active IP Right Cessation
- 2011-04-15 AU AU2011239489A patent/AU2011239489B2/en not_active Ceased
- 2011-04-15 CA CA2796496A patent/CA2796496C/en not_active Expired - Fee Related
- 2011-04-15 WO PCT/US2011/032736 patent/WO2011130669A1/en not_active Ceased
- 2011-04-15 ES ES11716154.7T patent/ES2501715T3/es active Active
- 2011-04-15 ES ES11716759T patent/ES2802609T3/es active Active
- 2011-04-15 EP EP11716759.3A patent/EP2558967B1/en active Active
- 2011-04-15 MX MX2012012062A patent/MX2012012062A/es active IP Right Grant
- 2011-04-15 EP EP20165684.0A patent/EP3706134A1/en not_active Withdrawn
- 2011-04-15 JP JP2013505189A patent/JP5747072B2/ja not_active Expired - Fee Related
- 2011-04-15 BR BR112012026361A patent/BR112012026361A2/pt not_active IP Right Cessation
- 2011-04-15 JP JP2013505190A patent/JP6018567B2/ja not_active Expired - Fee Related
- 2011-04-15 NZ NZ603010A patent/NZ603010A/en not_active IP Right Cessation
- 2011-04-15 AU AU2011239488A patent/AU2011239488B2/en not_active Ceased
- 2011-04-15 MX MX2017005496A patent/MX389975B/es unknown
- 2011-04-15 CA CA2796505A patent/CA2796505C/en not_active Expired - Fee Related
- 2011-04-15 EP EP11716154.7A patent/EP2558966B1/en not_active Not-in-force
- 2011-04-15 MX MX2015014313A patent/MX347513B/es unknown
- 2011-04-15 WO PCT/US2011/032735 patent/WO2011130668A1/en not_active Ceased
-
2012
- 2012-10-16 MX MX2022001536A patent/MX2022001536A/es unknown
- 2012-11-14 CO CO12205072A patent/CO6660434A2/es active IP Right Grant
- 2012-11-15 CO CO12207315A patent/CO6620023A2/es not_active Application Discontinuation
- 2012-11-15 CO CO12207312A patent/CO6630153A2/es unknown
-
2015
- 2015-05-11 JP JP2015096421A patent/JP6078582B2/ja active Active
- 2015-09-10 JP JP2015178146A patent/JP6043850B2/ja not_active Expired - Fee Related
-
2017
- 2017-01-16 JP JP2017005263A patent/JP6543279B2/ja not_active Expired - Fee Related
-
2019
- 2019-06-14 JP JP2019111351A patent/JP7057321B2/ja active Active
-
2022
- 2022-04-07 JP JP2022063908A patent/JP7438257B2/ja active Active
-
2024
- 2024-02-13 JP JP2024019498A patent/JP2024045513A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013524892A5 (https=) | ||
| JP2016535644A5 (https=) | ||
| Shiffman et al. | Living donor liver transplantation: summary of a conference at The National Institutes of Health | |
| JP7438257B2 (ja) | 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 | |
| JP2013506845A5 (https=) | ||
| Castellarnau et al. | Real-time Kt/V determination by ultraviolet absorbance in spent dialysate: technique validation | |
| EP2483685B1 (en) | Method of calculating a phosphorus-protein ratio | |
| US20100042331A1 (en) | Planning method and apparatus for peritoneal dialysis and hemodialysis hybrid remedy | |
| Eloot et al. | Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes | |
| Kloppenburg et al. | Anthropometry-based equations overestimate the urea distribution volume in hemodialysis patients | |
| Goldau et al. | Ionic dialysance measurement is urea distribution volume dependent: a new approach to better results | |
| Leypoldt et al. | Kinetics of urea and β2-microglobulin during and after short hemodialysis treatments | |
| Lunze et al. | Analysis and modelling of glucose metabolism in diabetic Göttingen Minipigs | |
| Stegeman et al. | Determination of protein catabolic rate in patients on chronic intermittent hemodialysis: Urea output measurements compared with dietary protein intake and with calculation of urea generation rate | |
| JP6857608B2 (ja) | 患者の濾過量を算定する方法および器械 | |
| Chen et al. | Estimating creatinine clearance in the nonsteady state: The determination and role of the true average creatinine concentration | |
| Hegbrant et al. | Residual renal phosphate clearance in patients receiving hemodialysis or hemodiafiltration | |
| Daugirdas | Changes in total protein concentration due to fluid removal during and shortly after hemodialysis | |
| Koroglu et al. | Importance of platelet markers for demonstrating the presence of inflammation in different stages of chronic renal diseases | |
| CN100493630C (zh) | 腹膜透析和血液透析并用计划方法以及腹膜透析和血液透析并用计划装置 | |
| Candan et al. | Dialysate CA125 levels after 5 years on continuous peritoneal dialysis | |
| Ruggero et al. | New models of phosphate kinetics in dialysis patients | |
| Micic et al. | Nitrogen Balance: Revisiting Clinical Applications in Contemporary Practice | |
| RU2009148236A (ru) | Способ снижения функциональной активности тромбоцитов у лиц молодого возраста с высоким нормальным артериальным давлением и избыточной массой тела | |
| Lelyavina et al. | Efficiency of 9-component heart failure rehabilitation program on exercise capacity and 3-year survival of heart failure patients |